Physician profile
Clinton John Carter
NPI 1679678270
$826.01
in general payments reported to CMS, 2019-2025
17 companies · $224 in 2025
The $224 reported for 2025 was more than what 84% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $51.03 · 2021: $49.25 · 2022: $207 · 2023: $204 · 2024: $90.27 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $185.68 | 2021-2025 | Ubrelvy |
| Novo Nordisk INC | $179.36 | 2023-2025 | Wegovy |
| Revance Therapeutics, INC. | $63.05 | 2025 | Daxxify |
| Lilly USA, LLC | $61.38 | 2022-2024 | Mounjaro, Zepbound |
| Acella Pharmaceuticals, LLC | $55.31 | 2024-2025 | NP Thyroid 60 |
| Genentech USA, INC. | $51.03 | 2020 | |
| Glaxosmithkline, LLC. | $31.20 | 2023 | Shingrix, Bexsero, Arexvy |
| Antares Pharma, INC. | $30.83 | 2025 | Xyosted |
| Neurocrine Biosciences, INC. | $24.90 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $24.02 | 2022 | |
| Exact Sciences Corporation | $20.91 | 2024 | Cologuard Collection Kit |
| Dexcom, INC. | $20.68 | 2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $20.67 | 2024 | |
| Itamar Medical INC | $17.66 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.98 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $13.23 | 2022 | |
| Pfizer INC. | $12.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.